Compare MetLife Inc. Common Stock (MET) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MetLife Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MetLife Inc. Common Stock trades at $98.33 (market cap $62.58B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: MetLife Inc. Common Stock is far larger — about 2.5× Royalty Pharma plc Class A Ordinary Shares's market cap, and MetLife Inc. Common Stock pays the higher dividend (2.41%). Which is the better fit depends on your goals — on Pluang, investors hold MetLife Inc. Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MET | RPRX | |
|---|---|---|
Market Cap | $62.58B | $25.27B |
Volume | 3,009,466 | 3,671,183 |
Sector | Financials | Health |
52-Week High | $99.95 | $63.96 |
52-Week Low | $67.70 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $83.50B | $32.50B |
Dividend Yield | 2.41% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
